New Liver Transpls Data Have Been Reported by Researchers at Yale University (Current Status: Meeting the Regulatory Goals of Your Liver Transplant Program)

2021 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Current study results on Transplant Medicine - Liver Transplants have been published. According to news reporting out of New Haven, Connecticut, by NewsRx editors, research stated, “The regulatory framework set by the Organ Procurement and Transplantation Network (OPTN) and Center for Medicare and Medicaid Services (CMS) for practice of liver transplantation in US is periodically updated and risk adjusted. Therefore, it is prudent for transplant centers to know the rules of engagement as it pertains to their practice.”

Our news journalists obtained a quote from the research from Yale University, “OPTN besides providing the regulatory oversight for safe and continued practice of transplant centers, provides necessary tools like: advanced statistical models and technological platforms to aid, and guide transplant centers including the necessary safeguards for high-quality transplant care. CMS regulations although had different thresholds to flag underperformance, often covered common grounds similar to the OPTN, therefore considered duplicative and unnecessary. But with much deliberation and consideration CMS undertook a major overhaul to the final rule for re-approval applications, a giant leap in the positive direction for transplant innovation and growth. The duplicative regulatory framework of OPTN and CMS has although achieved the goal of improving 1-year patient outcomes, it has proven costly in terms of slowing innovation, increasing organ discard and stunting growth of transplant volume.”

According to the news editors, the research concluded: “But the new updates in effect and also in the pipeline are a long-awaited opportunity for waiting transplant patients.”

This research has been peer-reviewed.

For more information on this research see: Current Status: Meeting the Regulatory Goals of Your Liver Transplant Program. Current Opinion in Organ Transplantation, 2021;26(2):146-151. Current Opinion in Organ Transplantation can be contacted at: Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA. (Lippincott Williams and Wilkins - www.lww.com; Current Opinion in Organ Transplantation - http://journals.lww.com/co-transplantation/pages/default.aspx)

Our news journalists report that additional information may be obtained by contacting David C. Mulligan, Yale University, Yale-New Haven Hospital, Div Transplantat & Immunol, School of Medicine, New Haven, CT 06520, United States.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1097/mot.0000000000000869. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)